Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04764643
What this trial is testing

The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Xijing Hospital of Digestive Diseases 140
Not applicableActive Not RecruitingNCT02276443
What this trial is testing

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 798
Testing effectiveness (Phase 2)Ended earlyNCT00853125
What this trial is testing

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Rutgers, The State University of New Jersey 10
Testing effectiveness (Phase 2)UnknownNCT05172440
What this trial is testing

A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC

Who this might be right for
Neoadjuvant Therapy
Hongqian Guo 20
Not applicableLooking for participantsNCT07587268
What this trial is testing

Molecular Profiling for Risk Stratification in Appendiceal Cancer

Who this might be right for
Appendiceal CancerAppendiceal Adenocarcinoma
City of Hope Medical Center 400
Early research (Phase 1)Study completedNCT03150810
What this trial is testing

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
BeiGene 139
Testing effectiveness (Phase 2)Ended earlyNCT00318110
What this trial is testing

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Center for International Blood and Marrow Transplant Research 4
Not applicableStudy completedNCT00089310
What this trial is testing

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 46
Not applicableStudy completedNCT03830710
What this trial is testing

8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions

Who this might be right for
Premalignant Lesion
Fayoum University 120
Large-scale testing (Phase 3)UnknownNCT06031597
What this trial is testing

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage III
Zhejiang Cancer Hospital 105
Testing effectiveness (Phase 2)Looking for participantsNCT05241249
What this trial is testing

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
Susan E. Bates 37
Testing effectiveness (Phase 2)Looking for participantsNCT02598349
What this trial is testing

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Proton Collaborative Group 60
Not applicableActive Not RecruitingNCT02889458
What this trial is testing

Hong Kong Breast Cancer Study

Who this might be right for
Breast CancerDuctal Carcinoma In Situ
The University of Hong Kong 7,000
Testing effectiveness (Phase 2)Ended earlyNCT00601848
What this trial is testing

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Who this might be right for
Lung CancerMetastatic Cancer
Abramson Cancer Center at Penn Medicine 9
Not applicableStudy completedNCT01182155
What this trial is testing

Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

Who this might be right for
Lung CancerNon-Small Cell Lung CancerSmall Cell Lung Cancer
Stanford University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04274426
What this trial is testing

Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer

Who this might be right for
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
AGO Research GmbH 136
Not applicableLooking for participantsNCT07618078
What this trial is testing

Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 900
Not applicableStudy completedNCT01097278
What this trial is testing

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
SWOG Cancer Research Network 208
Early research (Phase 1)Study completedNCT00028535
What this trial is testing

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Endometrial Carcinoma+4 more
National Cancer Institute (NCI) 18
Not applicableWithdrawnNCT00477425
What this trial is testing

Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab

Who this might be right for
Carcinoma
Genentech, Inc.
Next Page